1. Home
  2. VIPS vs RGEN Comparison

VIPS vs RGEN Comparison

Compare VIPS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vipshop Holdings Limited

VIPS

Vipshop Holdings Limited

HOLD

Current Price

$16.61

Market Cap

9.1B

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$163.11

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VIPS
RGEN
Founded
2008
1981
Country
China
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1B
8.2B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
VIPS
RGEN
Price
$16.61
$163.11
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$19.83
$174.90
AVG Volume (30 Days)
2.4M
597.5K
Earning Date
02-20-2026
02-19-2026
Dividend Yield
2.63%
N/A
EPS Growth
N/A
N/A
EPS
1.94
0.03
Revenue
$14,983,370,343.00
$707,890,000.00
Revenue This Year
$1.07
$17.86
Revenue Next Year
$2.36
$12.44
P/E Ratio
$9.40
$6,354.24
Revenue Growth
N/A
11.74
52 Week Low
$12.14
$102.97
52 Week High
$21.08
$182.52

Technical Indicators

Market Signals
Indicator
VIPS
RGEN
Relative Strength Index (RSI) 29.39 48.28
Support Level $17.74 $158.80
Resistance Level $18.86 $172.51
Average True Range (ATR) 0.69 6.24
MACD -0.08 -0.83
Stochastic Oscillator 1.55 25.84

Price Performance

Historical Comparison
VIPS
RGEN

About VIPS Vipshop Holdings Limited

Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners . As of March 31, 2025, Eric Ya Shen, chairman and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds an 12.5% interest.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: